Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6841 - 6848 of 12092 results

Another Chapter in California’s PAGA Saga
August 15, 2017| News

Spokeo Ruling Deals Blow To Cos. But May Have Silver Lining
August 15, 2017| News

Are You Ready for the New York August 28th Compliance Deadline?
August 14, 2017| Blog| Viewpoint

The Past, Present, and Future of Government Regulation of Off-Label Communications – Part 4
August 14, 2017| Blog| Viewpoint

Most Mass. businesses avoid full force of emissions rules — for now, anyway
August 13, 2017| News

CMS May Decide to Permit Labs to Bill for Certain Tests Provided to Outpatients
August 10, 2017| Blog| Viewpoint

The Latest Milestone In EB-5 Enforcement? Prison Time
August 10, 2017| News

'Made In America' — What You Need To Know Now
August 10, 2017| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
